Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: A translational research experience

Category Primary study
JournalBMC Cancer
Year 2006
This article has no abstract
Epistemonikos ID: 2eb25da40eb8e2a379d4976c3dc6e1f10aac29b2
First added on: Feb 04, 2025